At the end of the latest market close, ORIC Pharmaceuticals Inc. (ORIC) was valued at $4.33. In that particular session, Stock kicked-off at the price of $4.60 while reaching the peak value of $5.2381 and lowest value recorded on the day was $4.49. The stock current value is $4.99.Recently in News on March 16, 2023, ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates. Initial Phase 1b data for three ongoing clinical trials expected in second half of 2023: ORIC-533 in multiple myeloma, ORIC-114 in EGFR/HER2-mutated cancers, and ORIC-944 in prostate cancer. You can read further details here
ORIC Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $7.48 on 04/04/22, with the lowest value was $2.36 for the same time period, recorded on 11/04/22.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
ORIC Pharmaceuticals Inc. (ORIC) full year performance was -18.46%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ORIC Pharmaceuticals Inc. shares are logging -33.29% during the 52-week period from high price, and 111.44% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.36 and $7.48.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 622944 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the ORIC Pharmaceuticals Inc. (ORIC) recorded performance in the market was -15.28%, having the revenues showcasing 43.80% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 226.45M, as it employees total of 88 workers.
ORIC Pharmaceuticals Inc. (ORIC) in the eye of market guru’s
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.41, with a change in the price was noted +2.30. In a similar fashion, ORIC Pharmaceuticals Inc. posted a movement of +85.50% for the period of last 100 days, recording 672,722 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ORIC is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
ORIC Pharmaceuticals Inc. (ORIC): Stocks Technical analysis and Trends
Raw Stochastic average of ORIC Pharmaceuticals Inc. in the period of last 50 days is set at 32.61%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 78.39%. In the last 20 days, the company’s Stochastic %K was 52.15% and its Stochastic %D was recorded 43.90%.
If we look into the earlier routines of ORIC Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -15.28%. Additionally, trading for the stock in the period of the last six months notably improved by 52.13%, alongside a downfall of -18.46% for the period of the last 12 months. The shares increased approximately by 16.05% in the 7-day charts and went up by 4.83% in the period of the last 30 days. Common stock shares were driven by 43.80% during last recorded quarter.
